Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 12—December 2020
Dispatch

Human Rickettsiosis Caused by Rickettsia parkeri Strain Atlantic Rainforest, Urabá, Colombia

Margarita Arboleda, Leidy Y. Acevedo-Gutiérrez, Alejandra Ávila, Dairo Ospina, Francisco J. Díaz, David H. WalkerComments to Author , and Juan D. Rodas
Author affiliations: Instituto Colombiano de Medicina Tropical–CES, Medellín, Colombia (M. Arboleda); Universidad de Antioquia, Medellín (L.Y. Acevedo-Gutiérrez, F.J. Díaz, J.D. Rodas); Clínica Aurora y Universidad Pontificia Bolivariana, Medellín (A. Ávila); Clínica Chinita, Apartadó, Colombia (D. Ospina); University of Texas Medical Branch, Galveston, Texas, USA (D. Walker)

Cite This Article

Abstract

We describe the clinical, serologic, and molecular findings of a new human rickettsiosis in Colombia. Antibodies against Rickettsia spp. were detected. PCR showed amplification of genes for R. parkeri strain Atlantic Rainforest. This new rickettsiosis of minor virulence could explain some of the undifferentiated acute febrile diseases in Colombia.

Among the numerous causes of acute undifferentiated nonmalarial febrile illness, rickettsiae are amenable to treatment that can prevent death or, in the case of non–life-threatening diseases, shorten and ameliorate the course of illness (1). Awareness and knowledge of these infectious diseases are crucial and necessary. In Colombia, Rocky Mountain spotted fever was recognized in the 1930s and then rediscovered in the 21st century (2). Clusters of cases were documented in the departments of Cundinamarca, Córdoba, and Antioquia (24). Five fatal cases of Rocky Mountain spotted fever occurred in the village of Las Changas in the district of Necoclí in 2006, and 4 fatal cases occurred in a village in the district of Turbo in 2008 (4). Prevalence of antibodies to spotted fever group (SFG) rickettsiae of 25.6% among healthy residents of several areas in Colombia suggests contact of persons with less-virulent SFG rickettsiae, such as Rickettsia parkeri, which has previously been reported in Colombia in ticks of the species Amblyomma ovale, and R. amblyommatis, previously reported in A. cajennense ticks (57).

The Case

A previously healthy 47-year-old male farmer who lived in a rural area near the village of Puerto López in the district of Turbo, Department of Antioquia, Colombia, came to a clinic in Apartadó with a 5-day history of fever. He also reported chills, asthenia, nausea, loss of appetite, dark urine, and dysuria that began 1 day after discovery of a tick on the left flank of his abdomen. On physical examination he appeared to be in generally good condition; no rash was identified, and he was afebrile with normal vital signs.

Figure

Eschar of inoculation and lymphadenopathy in patient with febrile syndrome caused by a strain of Rickettsia parkeri, Colombia. A) A 1 .3 × 1.6 cm eschar with an erythematous halo is present at the site of a tick bite above the left iliac crest. B) A closer view reveals a brown-black crust and a collarette of desquamation. C) Distended skin overlying enlarged draining lymph nodes, 3.5 cm in length, is visible in the left inguinal region.

Figure. Eschar of inoculation and lymphadenopathy in patient with febrile syndrome caused by a strain of Rickettsia parkeri, Colombia.A) A 1 .3 × 1.6 cm eschar with...

A 13 × 16 mm crust with an erythematous halo and scaling collaret was seen above the left iliac crest at the site of the tick bite, accompanied by ipsilateral visible tender inguinal lymphadenopathy 3.5 cm in length (Figure). Results of the patient’s complete blood counts were within reference ranges, and blood smear detected no plasmodia.

Because of the eschar, draining lymphadenopathy, and history of tick bite, a rickettsial infection was suspected, and the patient was referred to the Colombian Institute of Tropical Medicine in Apartadó, Antioquia. There, a punch biopsy of the inoculation eschar and scraping of the eschar base and blood samples were obtained, and treatment with doxycycline (200 mg/d for 7 d) was initiated. The patient subsequently reported defervescence after 48 hours, with disappearance of symptoms and decreased lymphadenopathy.

The patient’s serum samples were examined by indirect immunofluorescence assay for antibodies reactive with 6 rickettsiae: R. rickettsii strain Uramita, R. parkeri strain At24, R. amblyommatis strain Ac37, R. rhipicephali strain HJ5, R. bellii strain Mogi, and Candidatus Rickettsia colombianensi (slides donated by Marcelo Labruna, Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo, São Paulo, Brazil). DNA was extracted from the eschar crust, eschar biopsy, and scrapings with the DNeasy Blood and Tissue kit (QIAGEN, https://www.qiagen.com), according to the manufacturer’s instructions. The samples were processed by PCR for gltA, sca0, sca4, and sca5 genes of Rickettsia using previously described primers and methods (8). The amplification products were sent for sequencing to Macrogen, and the sequences were analyzed with BLASTn (https://blast.ncbi.nlm.nih.gov), MEGA 7.0 (https://www.megasoftware.net), and MrBayes 3.2.6 (https://www.geneious.com). The human protocol was approved by the Bioethical Committee at the University of Antioquia (act 001/2016).

Indirect fluorescent antibody testing demonstrated seroconversion to all 6 Rickettsia antigens. Acute serum samples showed reactivity with none of the antigens at a titer of 64, whereas seroconversion to each of the antigens was observed by reactivity with R. parkeri (titer 1,024); R. rickettsii (titer 512); R. bellii (titer 256); and R. amblyommatis, Candidatus R. colombianensi, and R. rhipicephali (titer 128), without a quadruple difference between the different antigens.

Amplicons were obtained for all genes tested and all samples analyzed. All the sequences demonstrated 100% identity with R. parkeri strain Atlantic Rainforest and were submitted to GenBank (accession nos. MK860199–202).

Previous patients with rickettsial infections in the Department of Antioquia were gravely ill with rapid deterioration and respiratory and renal compromise, hepatic injury, and case-fatality rates of 28%–35% (4). In contrast, R. parkeri infections are mild or moderate acute febrile illnesses with fever, chills, headache, arthromyalgia, inoculation eschar, maculopapular or vesicular rash, and painful lymphadenopathy at lymphatic drainage sites of the entry lesion. Some patients do not manifest lymphadenopathy or, as in this patient, a rash (9).

In 2004, a new SFG human infection attributed to R. parkeri sensu stricto was described in the United States (10); later, Spolidorio et al. described a patient in Brazil with a clinically identical moderate febrile condition, with myalgia, arthralgia, and eschar, caused by a strain of R. parkeri designated Atlantic Rainforest (11). Human infections with similar signs and symptoms caused by R. parkeri sensu stricto and R. parkeri strain Atlantic Rainforest have been documented in the United States, Brazil, Uruguay, Argentina, and now in Colombia; meanwhile, these bacteria have also been demonstrated in ticks (in the absence of recognized human infections) in Bolivia, Peru, Nicaragua, Belize, and Mexico. Amblyomma maculatum, A. triste, and A. tigrinum ticks have been found infected with R. parkeri sensu stricto in nature; R. parkeri strain Atlantic Rainforest has been reported in A. ovale, A. aureolatum, and Dermacentor parumapertus ticks (12,13). R. parkeri strain Atlantic Rainforest was previously identified in A. ovale ticks in Colombia, where dogs are suspected of bringing the ticks into homes (6).

Conclusions

There may be a substantial unrecognized occurrence of R. parkeri infections in South and Central America. Increased awareness and knowledge by primary care physicians and establishment of effective national surveillance programs and guidelines, including empiric treatment with doxycycline, would lead to improved patient outcomes. Enhanced research to identify the range of vectors, vertebrate hosts, and risk factors to predict human exposure to this and other agents that may be causing similar diseases would contribute to the elucidation of the causes of acute febrile illnesses in Latin America.

Dr. Arboleda is the coordinator of the Colombian Institute of Tropical Medicine Branch in Apartado, Colombia. She works as a clinician, taking care of patients with endemic febrile diseases such as dengue, malaria, leptospirosis, and other acute undifferentiated febrile illnesses.

Top

Acknowledgments

We are grateful to Colciencias through the National Doctorate program (647/2014) and to Andrés Londoño for the confirmation of the ompA gene. We express our gratitude to the Fogarty International Center for the help and advice obtained through the Research Training Program on the Impact of Zoonotic and Vector-borne Viruses, Rickettsiae, and Leptospira in Acute Undifferentiated Febrile Illnesses (D43 TW010331).

The Universidad de Antioquia provided financial support through the CODI project 2014-321 and the Sustainability Program 2018–2019.

Top

References

  1. Lin  L, Decker  CF. Rocky Mountain spotted fever. Dis Mon. 2012;58:3619. DOIPubMedGoogle Scholar
  2. Patino  L, Afanador  A, Paul  JH. A spotted fever in Tobia, Colombia: preliminary report. Am J Trop Med Hyg. 1937;s1-17:63953.
  3. Hidalgo  M, Lizarazo  D, Ovalle  M, Castañeda  E, Heredia  D, Zambrano  P, et al. Brote de rickettsiosis en Los Córdobas, departamento de Córdoba, Febrero–Marzo 2007. Inf Quinc Epidemiol Nac. 2007;12:11820.
  4. Pacheco  O, Giraldo  M, Martinez  M, Hidalgo  M, Galeano  A, Echeverri  E, et al. Estudio de brote febril hemorrágico en el corregimiento de Alto de Mulatos—Distrito Especial Portuario de Turbo, Antioquia, enero de 2008. Inf Quinc Epidemiol Nac. 2008;13:14560.
  5. Quintero V  JC, Paternina T  LE, Uribe Y  A, Muskus  C, Hidalgo  M, Gil  J, et al. Eco-epidemiological analysis of rickettsial seropositivity in rural areas of Colombia: A multilevel approach. PLoS Negl Trop Dis. 2017;11:e0005892. DOIPubMedGoogle Scholar
  6. Faccini-Martínez  ÁA, Ramírez-Hernández  A, Forero-Becerra  E, Cortés-Vecino  JA, Escandón  P, Rodas  JD, et al. Molecular evidence of different Rickettsia species in Villeta, Colombia. Vector Borne Zoonotic Dis. 2016;16:857. DOIPubMedGoogle Scholar
  7. Londoño  AF, Díaz  FJ, Valbuena  G, Gazi  M, Labruna  MB, Hidalgo  M, et al. Infection of Amblyomma ovale by Rickettsia sp. strain Atlantic rainforest, Colombia. Ticks Tick Borne Dis. 2014;5:6725. DOIPubMedGoogle Scholar
  8. Oteo  JA, Nava  S, Sousa  R de , Mattar  S, Venzal  JM, Abarca  K, et al. Guías Latinoamericanas de la RIICER para el diagnóstico de las rickettsiosis transmitidas por garrapatas. Rev Chil Infectología. 2014;31:5465.
  9. Kelman  P, Thompson  CW, Hynes  W, Bergman  C, Lenahan  C, Brenner  JS, et al. Rickettsia parkeri infections diagnosed by eschar biopsy, Virginia, USA. Infection. 2018;46:55963. DOIPubMedGoogle Scholar
  10. Paddock  CD, Sumner  JW, Comer  JA, Zaki  SR, Goldsmith  CS, Goddard  J, et al. Rickettsia parkeri: a newly recognized cause of spotted fever rickettsiosis in the United States. Clin Infect Dis. 2004;38:80511. DOIPubMedGoogle Scholar
  11. Spolidorio  MG, Labruna  MB, Mantovani  E, Brandão  PE, Richtzenhain  LJ, Yoshinari  NH. Novel spotted fever group rickettsiosis, Brazil. Emerg Infect Dis. 2010;16:5213. DOIPubMedGoogle Scholar
  12. Parola  P, Paddock  CD, Socolovschi  C, Labruna  MB, Mediannikov  O, Kernif  T, et al. Update on tick-borne rickettsioses around the world: a geographic approach. Clin Microbiol Rev. 2013;26:657702. DOIPubMedGoogle Scholar
  13. Nieri-Bastos  FA, Marcili  A, De Sousa  R, Paddock  CD, Labruna  MB. Phylogenetic evidence for the existence of multiple strains of Rickettsia parkeri in the New World. Appl Environ Microbiol. 2018;84:e02872-17. DOIPubMedGoogle Scholar

Top

Figure

Top

Cite This Article

DOI: 10.3201/eid2612.200388

Original Publication Date: November 08, 2020

Table of Contents – Volume 26, Number 12—December 2020

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

David Walker, University of Texas Medical Branch, 301 University Blvd, Keiller Bldg, Galveston, TX 77555-0609, USA

Send To

10000 character(s) remaining.

Top

Page created: August 25, 2020
Page updated: November 19, 2020
Page reviewed: November 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external